Author Archives: Darren Marchal
EIA Data Reintroduces Natural Gas Volatility
After a period of very slow trading, the prompt month natural gas contract saw a trading range of 11.1 cents today, its largest since February 21st. Trading ranges had been historically low recently as the market coiled, with today’s move now fitting right in with past years. Prices initially traded lower only to then shoot…
What The EPS? EM Vs. DM Earnings Outlook
This week we look at the earnings outlook for emerging markets (EM) and developed markets (DM) – on both fronts I am specifically using the MSCI indexes, i.e. the MSCI Emerging Markets Index, and the MSCI World Index (as distinct from the MSCI ACWI). For the consensus earnings estimates I am using the Thomson Reuters…
Japanese Yen: Safe Haven Or Inflation Proxy?
In our last commentary on the Japanese yen, we wrote that the currency was looking excessively weak against the euro. In particular, we stated that bullish catalysts driving EUR/JPY were at risk as speculator positioning in both long euro and short yen trades were looking extreme. In addition, we flagged changes to the Bank of Japan’s…
Emerging Market Time Bomb: “Dollar Is Our Currency But Your
Emerging market risk is on the rise and the dollar has undergone huge fluctuations. Let’s tie this back to the origin. President Nixon’s Treasury Secretary, John Connally, famously told famously told a group of European finance ministers worried about the export of American inflation that the “dollar is our currency, but your problem.” On August 15,…
Short-Term Uptrend Is Doing Well
The relative strength of Commodities and Currencies favors higher stock prices. The Short and Medium-Term Trends The short-term uptrend is doing well, and I believe a new medium-term uptrend has started. Breadth indicators continue to support the uptrend. New highs are starting to look healthy, and new lows are at harmless levels. The Bullish Percents…
Nvidia (NVDA) Crushes Q1 Earnings Estimates, Revenue Surges 66%
Nvidia Corporation (NVDA – Free Report) just released its latest quarterly financial results, posting non-GAAP earnings of $2.05 per share and revenues of $3.21 billion. Currently, NVDA is a Zacks Rank #3 (Hold), but that could change based on today’s results. Shares of the company have gained about 13% over the past month, including a 1.7% gain during…
A Megatrend In Infancy Puts On Its Big Boy Pants
I was recently interviewed by Real Vision where I describe why I like DDD’s long-term prospects. In this post, I look at the current technical condition. On April 30th, 2 days before 3D Systems reported earnings, I sat with Real Vision in their studio in NY and told them why I was recommending this stock….
The Ceaseless Ascent
I’d like to off the following off-the-wall musings as a very different take on the market. It’s a disposition that many, many people share, and perhaps it would help me get in sync with the rest of the planet to actually type what everyone else is thinking. I type this to be neither facetious nor…
Biotech Stocks Underperform Market: CELG, EXEL, PBYI, XBI
Biotechs Underperform and Lag Market Indices on a Good Day-NASDAQ up 0.89% Trading Range Requires Good Stock Picking Skills, XBI is down 0.85% to $89.04. Stealth Buyout with Lilly Acquisition of ARMO BioSciences Biotechs underperformed despite a good opening with the XBI trying to break through the SMA 50 level but fell back around mid-day. Some good news helped…